F-star Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
35 Parkwood Drive, Babraham Research Campus, Cambridge, United Kingdom
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:55 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Mar 17, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2023
SC 13G/A Report Feb 15, 2022
SC 13G/A Report SCHEDULE 13G (AMENDMENT NO. 1) Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report AMENDMENT TO SC 13G Feb 14, 2022
SC 13G/A Report AMENDMENT TO SC 13G Feb 10, 2022
SC 13G/A Report Feb 8, 2022
SC 13G Report SCHEDULE 13G May 18, 2021
SC 13G Report May 17, 2021
SC 13G Report SC 13G May 17, 2021
SC 13G/A Report SC 13G/A Apr 9, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 4 TO THE SCHEDULE 13G Feb 16, 2021
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Feb 3, 2021
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Feb 3, 2021
SC 13G Report SC 13G Feb 1, 2021
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Nov 30, 2020
SC 13G/A Report SC 13G/A Apr 8, 2020
SC 13G/A Report AMENDMENT NO. 3 TO THE SCHEDULE 13G Feb 14, 2020
SC 13G/A Report SPRING BANK PHARMACEUTICALS, INC. Feb 12, 2020
SC 13G Report SC 13G Jan 6, 2020
SC 13G/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13G Feb 14, 2019
SC 13G/A Report KURT EICHLER SC 13G/A Feb 12, 2019
SC 13G Report SPRING BANK PHARMACEUTICALS, INC. Oct 18, 2018
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2018
SC 13G/A Report SC 13G/A Feb 12, 2018
SC 13G/A Report SC 13G/A Feb 12, 2018
SC 13G/A Report Feb 6, 2018
SC 13G Report SCHEDULE 13G Aug 11, 2017
SC 13G Report SC 13G Feb 10, 2017
SC 13G Report SC 13G Feb 10, 2017
SC 13G Report SC 13G Dec 5, 2016
SC 13G/A Report SC 13G/A Dec 5, 2016
SC 13G Report SC 13G Sep 19, 2016